Dinsmore Christopher 4
4 · Kronos Bio, Inc. · Filed Dec 15, 2021
Insider Transaction Report
Form 4
Kronos Bio, Inc.KRON
Dinsmore Christopher
Chief Scientific Officer
Transactions
- Sale
Common Stock
2021-12-13$12.36/sh−11,212$138,614→ 85,148 total - Sale
Common Stock
2021-12-13$12.82/sh−174$2,231→ 84,974 total
Footnotes (1)
- [F1]Represents shares sold to satisfy estimated tax withholding obligations upon the settlement of restricted stock units.